Genetic variations at loci involved in the immune response are risk factors for hepatocellular carcinoma - Wikidata - wikimedia - TriplyDB

Genetic variations at loci involved in the immune response are risk factors for hepatocellular carcinoma

Genetic variations at loci involved in the immune response are risk factors for hepatocellular carcinoma

http://www.wikidata.org/entity/Q28943313

about

New advances in hepatocellular carcinoma Genetic alterations in hepatocellular carcinoma: An update Telomerase reverse transcriptase locus polymorphisms and cancer risk: a field synopsis and meta-analysis Hepatitis C virus and hepatocarcinogenesis Functional short tandem repeat polymorphism of PTPN11 and susceptibility to hepatocellular carcinoma in Chinese populations Risk prediction models for hepatocellular carcinoma in different populations.Next generation sequencing gives an insight into the characteristics of highly selected breeds versus non-breed horses in the course of domestication.Viral hepatitis and hepatocellular carcinoma: etiology and management Genetic polymorphisms are associated with the risk of gastric and colorectal cancers in a Han Chinese population.Variants identified by hepatocellular carcinoma and chronic hepatitis B virus infection susceptibility GWAS associated with survival in HBV-related hepatocellular carcinoma.Pathways of distinction analysis: a new technique for multi-SNP analysis of GWAS data.A 3' UTR SNP in COL18A1 is associated with susceptibility to HBV related hepatocellular carcinoma in Chinese: three independent case-control studies Associations of pri-miR-34b/c and pre-miR-196a2 polymorphisms and their multiplicative interactions with hepatitis B virus mutations with hepatocellular carcinoma risk The 3' UTR variants in the GRP78 are not associated with overall survival in resectable hepatocellular carcinoma.Replication of genome wide association studies on hepatocellular carcinoma susceptibility loci in a Chinese population.Hepatocellular carcinoma: clinical frontiers and perspectives.Loss of heterozygosity at D8S262: an early genetic event of hepatocarcinogenesis.CASP 3 genetic polymorphisms and risk of Hepatocellular carcinoma: a case-control study in a Chinese population.Unrecognized sequence homologies may confound genome-wide association studies.Meta-analysis of DNA methylation biomarkers in hepatocellular carcinoma.A functional insertion/deletion polymorphism in the proximal promoter of CD3G is associated with susceptibility for hepatocellular carcinoma in Chinese population.Genetic variations in STAT4,C2,HLA-DRB1 and HLA-DQ associated with risk of hepatitis B virus-related liver cirrhosis.Germline DNA copy number variation in familial and early-onset breast cancer Programmed death-1 (PD-1) rs2227981 C > T polymorphism is associated with cancer susceptibility: a meta-analysis.Individualized hepatocellular carcinoma risk: the challenges for designing successful chemoprevention strategies.Combined effects of p53 and MDM2 polymorphisms on susceptibility and surgical prognosis in hepatitis B virus-related hepatocellular carcinoma.Human leukocyte antigens and epstein-barr virus-associated nasopharyngeal carcinoma: old associations offer new clues into the role of immunity in infection-associated cancers.Promoter polymorphisms of DNA methyltransferase 3B and risk of hepatocellular carcinoma.Association of the GLB1 rs4678680 genetic variant with risk of HBV-related hepatocellular carcinoma.Multi-ethnic studies in complex traits.Germline copy number variations and cancer predisposition.Hepatocellular carcinoma in chronic hepatitis C: from bench to bedside.Update on biomarkers of hepatocellular carcinoma.Genome-wide association studies of cancer in diverse populations.Systematical analyses of variants in DNase I hypersensitive sites identified two novel hepatocellular carcinoma susceptibility loci among Chinese population.Interaction of signal transducer and activator of transcription 3 polymorphisms with hepatitis B virus mutations in hepatocellular carcinoma.Genome-wide association studies: inherent limitations and future challenges.Genetic variants in cell death pathway genes and HBV-related hepatocellular carcinoma among a Chinese Han population.Application of Machine Learning to Development of Copy Number Variation-based Prediction of Cancer Risk Association of miRNA-122-binding site polymorphism at the interleukin-1 α gene and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk.

P2860

c8b233a1fd348de6c008751ae4947e588f6c05dd

P248

Q26749329-56EB89F2-6557-4FDE-A284-BC3CB72F2EBB Q28073241-7849FDA8-14BB-4E74-AE46-9263A0F68149 Q28265076-F9726EC1-C85B-44F5-8E05-A065F95724A0 Q28283484-B5E44518-F9D8-4608-AF12-BA7D884FB3D3 Q28542875-D3B8F78B-4BEF-4BBD-A5BE-D75641CF0668 Q30383460-3BA3E548-0287-4EE7-8D7B-D5D3B66D1A5A Q30583662-7D4A370F-CE7D-4B04-B112-A18AAC6DD480 Q33593219-D26AE552-7875-402E-85A1-115065127C79 Q33709900-4B8C50EC-16AE-4F13-AC54-8C5405A5BAE3 Q33838461-3F6FD5F9-6E22-4CFC-9FEA-1418575A3340 Q33939800-6150C2D3-2972-4DE6-A42A-FDAF99A77D91 Q34213827-B6523C1F-B2C3-4733-A65F-36A465BF0A5B Q34629791-817410EF-F25C-4355-8BEC-8DF21F3E7F58 Q34708309-2E7CEB3B-73ED-4475-A664-3D3EFBCB3CFD Q35035182-E3E3D01C-C0CB-4E09-929D-CFD7DBB61D4F Q35112053-C59550B7-8C2F-45B0-A1A9-F09AA4C9B302 Q35747284-2889C829-A59B-499F-A229-08FC84599BF7 Q35892035-5246ECD2-83C6-46B8-9C46-94856C00E065 Q36008184-A6847D61-CFE1-45F4-807D-9395F460CDAB Q36189699-70D5012A-7F94-463A-9DC3-B9B2764FAD5A Q36194154-F7F64821-B7D1-4893-A228-55B9E5A04A38 Q36250066-C238D20A-1C88-46D1-804F-6CE53EE37629 Q36393187-F9AB37D0-FBEE-4859-985A-EFFBE85F6F0F Q36511487-69ECA924-F030-4B76-A0D5-EE4321A3FFEE Q36699256-E846B056-C973-4C85-84F3-063439E26125 Q36923010-3D400111-B832-4C6D-AA61-1640CEA00C1B Q37376994-36DFA62C-DC33-4B2D-ACFE-961A8E594A33 Q37565314-B8054685-FC04-4FA4-8318-CBDD45C11A25 Q37636659-2D45E4E6-18F8-413B-920A-358465629F9C Q37926264-7DFD087B-2256-43A6-8AE2-117CA3519D6D Q38003668-9894433A-3ED9-4A30-A7D5-BB1CB2CC9398 Q38046452-7317A00B-9884-4A84-B260-9CB01259901D Q38166133-26DEA197-A915-4E68-BAF2-6BBC10570E07 Q38668307-8422AD88-03C9-48C3-9502-783858896D77 Q38891805-9CA8EE9A-16E8-4839-B0D8-26620B425046 Q39471805-960C854A-56BA-4A83-B89B-191178C4B0E2 Q39525714-8561E39B-DB7F-40F9-A37E-FB331A2ABBCC Q40148580-B033CEF7-3A1C-4829-9189-BAAAB54ED6B9 Q41715498-AD94F640-45BF-41DD-B154-17EC121EB685 Q42223486-866BCFCC-CE99-436C-93F4-57759E47586F

P2860

Genetic variations at loci involved in the immune response are risk factors for hepatocellular carcinoma

http://www.wikidata.org/entity/Q28943313

description

2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

artículu científicu espublizáu en 2010

@ast

im Dezember 2010 veröffentlichter wissenschaftlicher Artikel

@de

scientific journal article

@en

wetenschappelijk artikel (gepubliceerd op 2010/12/01)

@nl

наукова стаття, опублікована в грудні 2010

@uk

مقالة علمية (نشرت في ديسمبر 2010)

@ar

name

Genetic variations at loci inv ...... s for hepatocellular carcinoma

@ast

Genetic variations at loci inv ...... s for hepatocellular carcinoma

@en

type

label

Genetic variations at loci inv ...... s for hepatocellular carcinoma

@ast

Genetic variations at loci inv ...... s for hepatocellular carcinoma

@en

prefLabel

Genetic variations at loci inv ...... s for hepatocellular carcinoma

@ast

Genetic variations at loci inv ...... s for hepatocellular carcinoma

@en

P1433

Q28943313-30201689-8546-4156-B2AC-9598FAF554C0

P1476

Q28943313-B10494D5-40C8-4C65-91BB-C1F4F8C6863D

P2093

Q28943313-251DF43B-2BC8-4051-9F66-EA5BE1B88F7A

Q28943313-3128E1FE-A08C-4158-90D2-E63D26F432D5

Q28943313-4672DC5E-0DE8-44DC-938D-5C5DC2DE5AA4

Q28943313-4B0CD7F8-8A99-4E97-9A2D-496FA4CD0648

Q28943313-4BDD75AD-4F9F-437A-B72F-44876BAF3BAD

Q28943313-58057057-0FFF-4400-9446-D5395F2EB7F2

Q28943313-5E87E526-FC71-42D0-849D-D7B5E854B026

Q28943313-86D0A345-A21A-4B69-B216-EB018A6277FA

Q28943313-894DF0C5-BF7D-4538-A933-DF37A1E751FA

Q28943313-BCBC1A3E-2EF1-47DE-82D0-8AACB29EFBC9

P2860

Q28943313-9DE8DDCC-2F6F-45C6-91E7-ADEDEEC949C5

P304

Q28943313-A32775E7-60D0-4665-A36C-23E5F86DD043

P31

Q28943313-06204B7D-519A-471D-9DD1-41E5EEAFE902

P3181

Q28943313-BF742F95-C41C-4566-9C6E-A67D9650C74A

P356

Q28943313-A5153088-D6FF-43F1-A5E5-2228760BFA07

P407

Q28943313-CFC4C471-9539-4232-A3EC-D922866E2C8E

P433

Q28943313-B4D27B48-2F4D-4095-9D5F-08B9D3E4E49F

P478

Q28943313-1930976E-6F8A-48F9-86E3-5FB86411A12B

P50

Q28943313-D2991DC3-E678-40F1-91F5-6006ED4FAB4D

P577

Q28943313-2D31B7CD-3724-4C7F-967A-F60776487140

P5875

Q28943313-E5A4B688-6968-4CAC-83A7-D347ABBB6F41

P698

Q28943313-DD6C6A1B-7D2C-4420-AE01-00F78D8D7755

P3181

P356

P1433

P1476

Genetic variations at loci inv ...... s for hepatocellular carcinoma

@en

P2093

Chunhua Yan

http://www.w3.org/2001/XMLSchema#string

Constance M. Cultraro

http://www.w3.org/2001/XMLSchema#string

Cu V. Nguyen

http://www.w3.org/2001/XMLSchema#string

Daoud M. Meerzaman

http://www.w3.org/2001/XMLSchema#string

Gang Wu

http://www.w3.org/2001/XMLSchema#string

Hongen Zhang

http://www.w3.org/2001/XMLSchema#string

Il Han Song

http://www.w3.org/2001/XMLSchema#string

Jenny M. Kelley

http://www.w3.org/2001/XMLSchema#string

Jeong A. Kim

http://www.w3.org/2001/XMLSchema#string

Jinghui Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer burden in the year 2000. The global picture.

P304

2034–2043

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2533014

http://www.w3.org/2001/XMLSchema#string

P356

10.1002/HEP.23943

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

52

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49633448

http://www.w3.org/2001/XMLSchema#string

P698

21105107

http://www.w3.org/2001/XMLSchema#string